Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man
Saettone, M.F.; Giannaccini, B.; Teneggi, A.; Savigni, P.; Tellini, N.
Journal of Pharmacy and Pharmacology 34(7): 464-466
1982
ISSN/ISBN: 0022-3573 PMID: 6126549 Accession: 044951328
Full-Text Article emailed within 1 workday
Payments are secure & encrypted
References
Saettone, M.F.; Giannaccini, B.; Chetoni, P.; Galli, G.; Chiellini, E. 1984: Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpine Journal of Pharmacy and Pharmacology 36(4): 229-234Durrani, A.M.; Davies, N.M.; Thomas, M.; Kellaway, I.W. 1992: Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery syste M International Journal of Pharmaceutics 88(1-3): 409-415
Durrani, A.M.; Davis, N.M.; Tomas, M.; Kellaway, I.W. 1991: Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system Journal of Pharmacy and Pharmacology 43(Suppl): ABSTRACT 30P
Kelly, J.A.; Molyneux, P.D.; Smith, S.A.; Smith, S.E. 1989: Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations British Journal of Ophthalmology 73(5): 360-362
Sieg, J.W.; Robinson, J.R. 1977: Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine Journal of Pharmaceutical Sciences 66(9): 1222-1228
Camber, O.; Edman, P. 1989: Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine Current Eye Research 8(6): 563-567
Dumitriu, S.; Vancea, P.; Costin, D.; Popa, M. 1987: Bioactive polymers XXXIX. Retarded ophthalmic drugs base on pilocarpine and xanthan derivatives Clinical Materials 2(2): 141-152
Sieg, J.W.; Robinson, J.R. 1979: Vehicle effects on ocular drug bioavailability III: Shear-facilitated pilocarpine release from ointments Journal of Pharmaceutical Sciences 68(6): 724-728
Zinyemba, E.; Morton, D.J. 1991: Effect of change in vehicle composition on ophthalmic bioavailability of benzylpenicillin Journal of Clinical Pharmacy and Therapeutics 16(6): 477-481
Han, S.; Shen, J-qiu.; Gan, Y.; Geng, H-ming.; Zhang, X-xin.; Zhu, C-liu.; Gan, L. 2010: Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability Acta Pharmacologica Sinica 31(8): 990-998
Ellis, P.P.; Riegel, M. 1989: Influence of ophthalmic ointments on the penetration of pilocarpine drops Journal of Ocular Pharmacology 5(2): 119-125
Kreienbaum, M.A.; Page, D.P. 1986: Stability of pilocarpine hydrochloride and pilocarpine nitrate ophthalmic solutions submitted by U.S. hospitals American Journal of Hospital Pharmacy 43(1): 109-117
Jackson, M.A.; Giyanani, J.; Shabaik, Y.; Penzner, J.; Gore, A.V.; Robinson, M.R.; Waring, G.O. 2022: In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment Ophthalmology and Therapy 11(2): 869-879
Hartmann, V.; Keipert, S. 1996: Influence of divalent cations on deacetylated gellan and pilocarpine containing ophthalmic preparations Pharmaceutical and Pharmacological Letters 6(3): 98-101
Brian, B.; Boltralik, J.J.; Thom, L.; Zeleznick, L.D. 1974: Ophthalmic bioavailability. I. Corneal penetration of aceclidine (3-acetoxyquinuclidine) into the rabbit eye using a perfusion technique Journal of Pharmaceutical Sciences 63(4): 633-635
Greaves, J.L.; Wilson, C.G.; Rozier, A.; Grove, J.; Plazonnet, B. 1990: Scintigraphic assessment of an ophthalmic gelling vehicle in man and rabbit Current Eye Research 9(5): 415-420
Mitra, A.K.; Mikkelson, T.J. 1987: Ophthalmic solution buffer systems ii. effects of buffer type and concentration on the ocular absorption of pilocarpine and a method of ocular bioavailability prediction from physicochemical data International Journal of Pharmaceutics 37(1-2): 19-26
Borgmann, H.; Wurster, W. 1973: Influence of different concentrations and of vehicle on pilocarpine miosis Klinische Monatsblatter für Augenheilkunde 163(1): 44-50
Walenga, R.L.; Babiskin, A.H.; Zhang, X.; Absar, M.; Zhao, L.; Lionberger, R.A. 2019: Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup time Journal of Pharmaceutical Sciences 108(1): 620-629
Lippold, B.C.; Reimann, H. 1989: Influence of vehicle on drug action in solution type methylnicotinate ointments part ii relationship between relative thermodynamic activity and bioavailability penetration enhancing and unloading effects Acta Pharmaceutica Technologica 35(3): 136-142